Balance Sheet
Accounts PayablesAccumulated ExpensesAssetsCash & Current InvestmentsCash & EquivalentsCommon EquityCurrent AssetsCurrent Deferred RevenueCurrent LeasesGoodwill & IntangiblesIntangiblesInventoryLiabilities and Shareholders EquityNon-Current AssetsNon-Current Deffered RevenueOperating LeasesOther Non-Current AssetsPayablesPrepaid AssetsProperty, Plant & Equipment (Net)ReceivablesRetained EarningsShareholder's EquityTotal Current LiabilitiesTotal LiabilitiesTreasury Shares
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Ratios

Niagen Bioscience (NAGE) Non-Current Deferred Tax Liability (2016 - 2018)

Niagen Bioscience (NAGE) has disclosed Non-Current Deferred Tax Liability for 3 consecutive years, with $137000.0 as the latest value for Q4 2018.

  • Quarterly Non-Current Deferred Tax Liability rose 621.05% to $137000.0 in Q4 2018 from the year-ago period, while the trailing twelve-month figure was $137000.0 through Dec 2018, up 621.05% year-over-year, with the annual reading at $137000.0 for FY2018, 621.05% up from the prior year.
  • Non-Current Deferred Tax Liability for Q4 2018 was $137000.0 at Niagen Bioscience, up from $19000.0 in the prior quarter.
  • The five-year high for Non-Current Deferred Tax Liability was $399000.0 in Q4 2016, with the low at $19000.0 in Q4 2017.
  • Average Non-Current Deferred Tax Liability over 3 years is $185000.0, with a median of $137000.0 recorded in 2018.
  • The sharpest move saw Non-Current Deferred Tax Liability plummeted 95.24% in 2017, then surged 621.05% in 2018.
  • Over 3 years, Non-Current Deferred Tax Liability stood at $399000.0 in 2016, then tumbled by 95.24% to $19000.0 in 2017, then soared by 621.05% to $137000.0 in 2018.
  • According to Business Quant data, Non-Current Deferred Tax Liability over the past three periods came in at $137000.0, $19000.0, and $399000.0 for Q4 2018, Q4 2017, and Q4 2016 respectively.